Rapid Diagnostic Tests and Their Effect on Antimicrobial Stewardship
![](https://www.t2biosystems.com/wp-content/uploads/2021/11/Infectious-Disease-Special-Edition-11.jpg)
T2 Biosystems Readies Biothreat Panel for FDA Submission While Keeping Eye on Sepsis Market
![](https://www.t2biosystems.com/wp-content/uploads/2021/11/Genomeweb-MB-14.jpg)
Increasing HAIs due to COVID-19 Stress the Need for a New Approach to Sepsis Diagnostics
![](https://www.t2biosystems.com/wp-content/uploads/2022/11/CLN.jpg)
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
T2 Biosystems awarded 100K for Lyme panel from HHS, Steven & Alexandra Cohen Foundation
![](https://www.t2biosystems.com/wp-content/uploads/2022/09/Labpulse.jpg)
Real-World Reports About Rapid Diagnostic Testing
![](https://www.t2biosystems.com/wp-content/uploads/2021/11/Infectious-Disease-Special-Edition-11.jpg)
T2 Biosystems inks distribution agreement in Baltic region
![](https://www.t2biosystems.com/wp-content/uploads/2022/09/Labpulse.jpg)
FDA grants breakthrough device designation for T2 Biosystems’ T2Lyme Panel
![](https://www.t2biosystems.com/wp-content/uploads/2022/07/medical-device-network.jpg)